WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera, Inc. (OTCBB:GTHA) is pleased to update its shareholders with this release announcing the continuation of work done earlier by the Company on RNA Interference (RNAi) in its Colorado laboratory.
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera, Inc. (OTCBB:GTHA) is pleased to update its shareholders with this release announcing the continuation of work done earlier by the Company on RNA Interference (RNAi) in its Colorado laboratory.